Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

Published:2023-12 Issue: Volume: Page:
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Oda Yoshiaki,Kumagai Yuji,Kanai Manabu,Iwama Yasuhiro,Okura Iori,Minamida Takeshi,Yagi Yukihiro,Kurosawa Toru,Greener Benjamin,Zhang Ye,Walson Judd L

Funder

Japan Labour Health and Welfare Organization

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference25 articles.

1. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines;Araf;J Med Virol,2022

2. COVID-19 vaccine—long term immune decline and breakthrough infections;Khoury;Vaccine,2021

3. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost;Ai;Emerg Microbes Infect,2022

4. Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?;Jung;J Virol,2022

5. Vaccine effectiveness of primary series and booster doses against COVID-19 associated hospital admissions in the United States: living test negative design study;Adams;BMJ,2022

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the design and delivery of RNA vaccines for infectious diseases;Advanced Drug Delivery Reviews;2024-10

2. mRNA medicine: Recent progresses in chemical modification, design, and engineering;Nano Research;2024-09-03

3. Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends;Journal of Controlled Release;2024-09

4. Advances in Dendritic-Cell-Based Vaccines against Respiratory Fungal Infections;Vaccines;2024-08-28

5. Immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines for SARS-CoV-2;2024-08-27